BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33278494)

  • 1. Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells.
    Shabana AM; Kambhampati SP; Hsia RC; Kannan RM; Kokkoli E
    Int J Pharm; 2021 Jan; 593():120139. PubMed ID: 33278494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
    Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
    Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
    Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
    Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine and rapamycin-loaded mixed polymeric thermogel for metastatic pancreatic cancer therapy.
    Kim SY; Jo MJ; Yoon MS; Jin CE; Shin YB; Lee JM; Shin HJ; Oh JG; Cho JM; Kim H; Park H; Choi YW; Park CW; Kim JS; Shin DH
    J Control Release; 2023 Aug; 360():796-809. PubMed ID: 37437850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
    Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
    Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
    Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
    Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel.
    Yang D; Ning J; Liao X; Jiang H; Qin S
    Int J Nanomedicine; 2023; 18():3989-4005. PubMed ID: 37496690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.
    Liu Y; Tamam H; Yeo Y
    AAPS PharmSciTech; 2018 Feb; 19(2):693-699. PubMed ID: 28971370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of a Thermosensitive Gel Composed of a mPEG-PLGA-PLL-cRGD Nanodrug Delivery System for Pancreatic Tumor Therapy.
    Shen M; Xu YY; Sun Y; Han BS; Duan YR
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20530-7. PubMed ID: 26366977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment.
    Kong X; Feng M; Wu L; He Y; Mao H; Gu Z
    Drug Deliv; 2022 Dec; 29(1):1595-1607. PubMed ID: 35612309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
    Liang Y; Dong C; Zhang J; Deng L; Dong A
    Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.
    Rajeshkumar NV; Yabuuchi S; Pai SG; Tong Z; Hou S; Bateman S; Pierce DW; Heise C; Von Hoff DD; Maitra A; Hidalgo M
    Br J Cancer; 2016 Aug; 115(4):442-53. PubMed ID: 27441498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
    Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
    PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.
    Singh A; Xu J; Mattheolabakis G; Amiji M
    Nanomedicine; 2016 Apr; 12(3):589-600. PubMed ID: 26656632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.